CoChat

Effect of IL‐6 polymorphism on risk of Alzheimer disease: Genotype‐phenotype association study in Japanese cases

Shibata, Nobuto, Ohnuma, Tohru, Takahashi, Tadashi, Baba, Hajime, Ishizuka, Takuya, Ohtsuka, Mieko, Ueki, Akira, Nagao, Masatsugu, Arai, Heii · 2002 · American Journal of Medical Genetics
Cited by 80

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Interleukin‐6 (IL‐6), an inflammatory cytokine might be involved in the pathophysiology of Alzheimer disease (AD); several studies have reported that the “C allele of IL‐6 variable number of tandem repeat polymorphism” (IL‐6vntr) delayed initial onset of AD and also decreased its risk per se. Another polymorphism, G/C allele of IL‐6 gene promoter region (IL‐6prom), is also a candidate because it has an influence on the regulation of plasma IL‐6 concentration. We examined these IL‐6 polymorphisms in 128 Japanese AD cases and 83 control cases using a PCR‐RFLP method. The results showed the frequency of the IL‐6prom G allele was significantly increased in AD, although IL‐6vntr polymorphism was not. Plasma IL‐6 concentration of the AD cases was also significantly higher than that of the control cases. Moreover, the IL‐6prom G allele‐positive AD patients showed a tendency to have higher IL‐6 concentration in the AD group. These findings suggest that the IL‐6prom G allele which may affect plasma IL‐6 concentration might be a risk factor for sporadic AD in Japanese. © 2002 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ajmg.10417

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

Metadata

Authors
Shibata, N., Ohnuma, T., Takahashi, T., Baba, H., Ishizuka, T., Ohtsuka, M., Ueki, A., Nagao, M., & Arai, H.
Venue
American Journal of Medical Genetics
Publisher
Wiley
Published
2002-05-08
Volume
114
Issue
4
Pages
436-439
ISSN
  • 0148-7299 (ISSN-L)
  • 1096-8628
OpenAlex
W2099910279
Cited by
80
References
5
FWCI
3.31
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.